Biotech ETFs try to Fend off Mounting Skepticism

The major biotechnology exchange traded funds closed higher Monday and it is good thing considering last week’s less-than-impressive performances from the high-flying group. Biotech ETFs have recently shown vulnerability. For example, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.